Clinical spectrum of allergic and pseudoallergic drug reactions
Among the many types of adverse effects of drugs, allergic reactions constitute a very significant minority, with respect to both their frequency and sometimes serious consequences. To keep the term “drug allergy” meaningful, it should be limited to those adverse drug reactions that are based on imm...
Gespeichert in:
Veröffentlicht in: | Journal of allergy and clinical immunology 1984-10, Vol.74 (4), p.558-566 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 566 |
---|---|
container_issue | 4 |
container_start_page | 558 |
container_title | Journal of allergy and clinical immunology |
container_volume | 74 |
creator | Mathews, Kenneth P. |
description | Among the many types of adverse effects of drugs, allergic reactions constitute a very significant minority, with respect to both their frequency and sometimes serious consequences. To keep the term “drug allergy” meaningful, it should be limited to those adverse drug reactions that are based on immune mechanisms or that can reasonably be presumed to have this basis. Pseudoallergic drug reactions, which will also be considered in this issue, have similar clinical manifestations and some common pathogenetic mechanisms, but the initiating event does not appear to involve a reaction between the drug or a drug metabolite and specific antibodies. Clinically, drug allergy is commonly observed in nonatopic as well as atopic people. Innumerable drugs have been reported to produce these types of reactions, but in many instances drug metabolites may be the actual culprits. Clinical manifestations of drug allergy also are legion. Unfortunately, essentially none of these is unique or specific for drug allergy, but it is important for clinicians to think of this very treatable condition along with other diagnostic possibilities. It is convenient and helpful to classify allergic reactions to drugs according to Gell and Coombs' four main types of hypersensitivity processes, but in many instances more than one mechanism may be involved, just as immune responses to most antigens generally are complex. Type I reactions are generally immunoglobulin (Ig) E-mediated, and clinical manifestations include urticaria, angioedema, respiratory symptoms, and anaphylaxis. Pseudoallergic reactions of the latter type are called anaphylactoid. Type II reactions to drugs are less common but could be exemplified by hemolytic anemia after α-methyldopa administration. Type III reactions, caused by immune complexes, would be exemplified by serum sickness, various types of vasculitis, or “innocent bystander” types of hematologic reactions. Type IV reactions, which are related to cell-mediated immune responses, are exemplified by allergic contact dermatitis from ointments or allergic photodermatitis. Numerous other types of drug allergy also may fall in this category. As iatrogenic illnesses, at least some drug allergies should be preventable. The most important prophylactic measure is for physicians to routinely ask about adverse effects from previous medications before prescribing drugs. |
doi_str_mv | 10.1016/0091-6749(84)90107-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_14250631</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0091674984901076</els_id><sourcerecordid>14250631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-32409c03311369b3df663bcda6a8acea6bc82e524534380279cead4aa1e789bb3</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMotVbfQGFWoovR3CaTbBQp3qDgRtchk5wpkbmZzAi-vaktXbo6t__8h_MhdE7wDcFE3GKsSC5Krq4kv1aY4DIXB2hOsEqJpMUhmu8lx-gkxk-caibVDM0ExZIyOkf3y8Z33pomiwPYMUxt1teZaRoIa28z07lsiDC5ft9yYVpnAYwdfd_FU3RUmybC2S4u0MfT4_vyJV-9Pb8uH1a5LTAec0Y5VhYzRggTqmKuFoJV1hlhpLFgRGUlhYLygnEmMS1VajpuDIFSqqpiC3S59R1C_zVBHHXro4WmMR30U9SE0wILRpKQb4U29DEGqPUQfGvCjyZYb7jpDRS9gaIl13_ctEhrFzv_qWrB7Zd2oNL8bjuH9OS3h6Cj9dBZcD4kbtr1_v8Dv5I-fDI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14250631</pqid></control><display><type>article</type><title>Clinical spectrum of allergic and pseudoallergic drug reactions</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Mathews, Kenneth P.</creator><creatorcontrib>Mathews, Kenneth P.</creatorcontrib><description>Among the many types of adverse effects of drugs, allergic reactions constitute a very significant minority, with respect to both their frequency and sometimes serious consequences. To keep the term “drug allergy” meaningful, it should be limited to those adverse drug reactions that are based on immune mechanisms or that can reasonably be presumed to have this basis. Pseudoallergic drug reactions, which will also be considered in this issue, have similar clinical manifestations and some common pathogenetic mechanisms, but the initiating event does not appear to involve a reaction between the drug or a drug metabolite and specific antibodies. Clinically, drug allergy is commonly observed in nonatopic as well as atopic people. Innumerable drugs have been reported to produce these types of reactions, but in many instances drug metabolites may be the actual culprits. Clinical manifestations of drug allergy also are legion. Unfortunately, essentially none of these is unique or specific for drug allergy, but it is important for clinicians to think of this very treatable condition along with other diagnostic possibilities. It is convenient and helpful to classify allergic reactions to drugs according to Gell and Coombs' four main types of hypersensitivity processes, but in many instances more than one mechanism may be involved, just as immune responses to most antigens generally are complex. Type I reactions are generally immunoglobulin (Ig) E-mediated, and clinical manifestations include urticaria, angioedema, respiratory symptoms, and anaphylaxis. Pseudoallergic reactions of the latter type are called anaphylactoid. Type II reactions to drugs are less common but could be exemplified by hemolytic anemia after α-methyldopa administration. Type III reactions, caused by immune complexes, would be exemplified by serum sickness, various types of vasculitis, or “innocent bystander” types of hematologic reactions. Type IV reactions, which are related to cell-mediated immune responses, are exemplified by allergic contact dermatitis from ointments or allergic photodermatitis. Numerous other types of drug allergy also may fall in this category. As iatrogenic illnesses, at least some drug allergies should be preventable. The most important prophylactic measure is for physicians to routinely ask about adverse effects from previous medications before prescribing drugs.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/0091-6749(84)90107-6</identifier><identifier>PMID: 6208232</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Anaphylatoxins - pharmacology ; Anaphylaxis - immunology ; Angioedema - immunology ; Antibody-Dependent Cell Cytotoxicity ; Antigen-Antibody Complex - adverse effects ; Basophils - immunology ; Dermatitis, Contact - immunology ; Drug Hypersensitivity - classification ; Drug Hypersensitivity - immunology ; Erythema Nodosum - chemically induced ; Histamine Release - drug effects ; Humans ; Iatrogenic Disease ; Immunoglobulin E - immunology ; Ionophores - pharmacology ; Mast Cells - immunology ; Penicillins - adverse effects ; Respiratory Tract Diseases - immunology ; Urticaria - immunology</subject><ispartof>Journal of allergy and clinical immunology, 1984-10, Vol.74 (4), p.558-566</ispartof><rights>1984</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-32409c03311369b3df663bcda6a8acea6bc82e524534380279cead4aa1e789bb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0091674984901076$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6208232$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mathews, Kenneth P.</creatorcontrib><title>Clinical spectrum of allergic and pseudoallergic drug reactions</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>Among the many types of adverse effects of drugs, allergic reactions constitute a very significant minority, with respect to both their frequency and sometimes serious consequences. To keep the term “drug allergy” meaningful, it should be limited to those adverse drug reactions that are based on immune mechanisms or that can reasonably be presumed to have this basis. Pseudoallergic drug reactions, which will also be considered in this issue, have similar clinical manifestations and some common pathogenetic mechanisms, but the initiating event does not appear to involve a reaction between the drug or a drug metabolite and specific antibodies. Clinically, drug allergy is commonly observed in nonatopic as well as atopic people. Innumerable drugs have been reported to produce these types of reactions, but in many instances drug metabolites may be the actual culprits. Clinical manifestations of drug allergy also are legion. Unfortunately, essentially none of these is unique or specific for drug allergy, but it is important for clinicians to think of this very treatable condition along with other diagnostic possibilities. It is convenient and helpful to classify allergic reactions to drugs according to Gell and Coombs' four main types of hypersensitivity processes, but in many instances more than one mechanism may be involved, just as immune responses to most antigens generally are complex. Type I reactions are generally immunoglobulin (Ig) E-mediated, and clinical manifestations include urticaria, angioedema, respiratory symptoms, and anaphylaxis. Pseudoallergic reactions of the latter type are called anaphylactoid. Type II reactions to drugs are less common but could be exemplified by hemolytic anemia after α-methyldopa administration. Type III reactions, caused by immune complexes, would be exemplified by serum sickness, various types of vasculitis, or “innocent bystander” types of hematologic reactions. Type IV reactions, which are related to cell-mediated immune responses, are exemplified by allergic contact dermatitis from ointments or allergic photodermatitis. Numerous other types of drug allergy also may fall in this category. As iatrogenic illnesses, at least some drug allergies should be preventable. The most important prophylactic measure is for physicians to routinely ask about adverse effects from previous medications before prescribing drugs.</description><subject>Anaphylatoxins - pharmacology</subject><subject>Anaphylaxis - immunology</subject><subject>Angioedema - immunology</subject><subject>Antibody-Dependent Cell Cytotoxicity</subject><subject>Antigen-Antibody Complex - adverse effects</subject><subject>Basophils - immunology</subject><subject>Dermatitis, Contact - immunology</subject><subject>Drug Hypersensitivity - classification</subject><subject>Drug Hypersensitivity - immunology</subject><subject>Erythema Nodosum - chemically induced</subject><subject>Histamine Release - drug effects</subject><subject>Humans</subject><subject>Iatrogenic Disease</subject><subject>Immunoglobulin E - immunology</subject><subject>Ionophores - pharmacology</subject><subject>Mast Cells - immunology</subject><subject>Penicillins - adverse effects</subject><subject>Respiratory Tract Diseases - immunology</subject><subject>Urticaria - immunology</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKAzEUhoMotVbfQGFWoovR3CaTbBQp3qDgRtchk5wpkbmZzAi-vaktXbo6t__8h_MhdE7wDcFE3GKsSC5Krq4kv1aY4DIXB2hOsEqJpMUhmu8lx-gkxk-caibVDM0ExZIyOkf3y8Z33pomiwPYMUxt1teZaRoIa28z07lsiDC5ft9yYVpnAYwdfd_FU3RUmybC2S4u0MfT4_vyJV-9Pb8uH1a5LTAec0Y5VhYzRggTqmKuFoJV1hlhpLFgRGUlhYLygnEmMS1VajpuDIFSqqpiC3S59R1C_zVBHHXro4WmMR30U9SE0wILRpKQb4U29DEGqPUQfGvCjyZYb7jpDRS9gaIl13_ctEhrFzv_qWrB7Zd2oNL8bjuH9OS3h6Cj9dBZcD4kbtr1_v8Dv5I-fDI</recordid><startdate>198410</startdate><enddate>198410</enddate><creator>Mathews, Kenneth P.</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>198410</creationdate><title>Clinical spectrum of allergic and pseudoallergic drug reactions</title><author>Mathews, Kenneth P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-32409c03311369b3df663bcda6a8acea6bc82e524534380279cead4aa1e789bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Anaphylatoxins - pharmacology</topic><topic>Anaphylaxis - immunology</topic><topic>Angioedema - immunology</topic><topic>Antibody-Dependent Cell Cytotoxicity</topic><topic>Antigen-Antibody Complex - adverse effects</topic><topic>Basophils - immunology</topic><topic>Dermatitis, Contact - immunology</topic><topic>Drug Hypersensitivity - classification</topic><topic>Drug Hypersensitivity - immunology</topic><topic>Erythema Nodosum - chemically induced</topic><topic>Histamine Release - drug effects</topic><topic>Humans</topic><topic>Iatrogenic Disease</topic><topic>Immunoglobulin E - immunology</topic><topic>Ionophores - pharmacology</topic><topic>Mast Cells - immunology</topic><topic>Penicillins - adverse effects</topic><topic>Respiratory Tract Diseases - immunology</topic><topic>Urticaria - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mathews, Kenneth P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mathews, Kenneth P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical spectrum of allergic and pseudoallergic drug reactions</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>1984-10</date><risdate>1984</risdate><volume>74</volume><issue>4</issue><spage>558</spage><epage>566</epage><pages>558-566</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Among the many types of adverse effects of drugs, allergic reactions constitute a very significant minority, with respect to both their frequency and sometimes serious consequences. To keep the term “drug allergy” meaningful, it should be limited to those adverse drug reactions that are based on immune mechanisms or that can reasonably be presumed to have this basis. Pseudoallergic drug reactions, which will also be considered in this issue, have similar clinical manifestations and some common pathogenetic mechanisms, but the initiating event does not appear to involve a reaction between the drug or a drug metabolite and specific antibodies. Clinically, drug allergy is commonly observed in nonatopic as well as atopic people. Innumerable drugs have been reported to produce these types of reactions, but in many instances drug metabolites may be the actual culprits. Clinical manifestations of drug allergy also are legion. Unfortunately, essentially none of these is unique or specific for drug allergy, but it is important for clinicians to think of this very treatable condition along with other diagnostic possibilities. It is convenient and helpful to classify allergic reactions to drugs according to Gell and Coombs' four main types of hypersensitivity processes, but in many instances more than one mechanism may be involved, just as immune responses to most antigens generally are complex. Type I reactions are generally immunoglobulin (Ig) E-mediated, and clinical manifestations include urticaria, angioedema, respiratory symptoms, and anaphylaxis. Pseudoallergic reactions of the latter type are called anaphylactoid. Type II reactions to drugs are less common but could be exemplified by hemolytic anemia after α-methyldopa administration. Type III reactions, caused by immune complexes, would be exemplified by serum sickness, various types of vasculitis, or “innocent bystander” types of hematologic reactions. Type IV reactions, which are related to cell-mediated immune responses, are exemplified by allergic contact dermatitis from ointments or allergic photodermatitis. Numerous other types of drug allergy also may fall in this category. As iatrogenic illnesses, at least some drug allergies should be preventable. The most important prophylactic measure is for physicians to routinely ask about adverse effects from previous medications before prescribing drugs.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>6208232</pmid><doi>10.1016/0091-6749(84)90107-6</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-6749 |
ispartof | Journal of allergy and clinical immunology, 1984-10, Vol.74 (4), p.558-566 |
issn | 0091-6749 1097-6825 |
language | eng |
recordid | cdi_proquest_miscellaneous_14250631 |
source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Anaphylatoxins - pharmacology Anaphylaxis - immunology Angioedema - immunology Antibody-Dependent Cell Cytotoxicity Antigen-Antibody Complex - adverse effects Basophils - immunology Dermatitis, Contact - immunology Drug Hypersensitivity - classification Drug Hypersensitivity - immunology Erythema Nodosum - chemically induced Histamine Release - drug effects Humans Iatrogenic Disease Immunoglobulin E - immunology Ionophores - pharmacology Mast Cells - immunology Penicillins - adverse effects Respiratory Tract Diseases - immunology Urticaria - immunology |
title | Clinical spectrum of allergic and pseudoallergic drug reactions |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T05%3A16%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20spectrum%20of%20allergic%20and%20pseudoallergic%20drug%20reactions&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Mathews,%20Kenneth%20P.&rft.date=1984-10&rft.volume=74&rft.issue=4&rft.spage=558&rft.epage=566&rft.pages=558-566&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/0091-6749(84)90107-6&rft_dat=%3Cproquest_cross%3E14250631%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14250631&rft_id=info:pmid/6208232&rft_els_id=0091674984901076&rfr_iscdi=true |